Valuation: Grand Pharmaceutical Group Limited

Market Cap 18.33B 2.34B 2.02B 1.89B 1.73B 3.26B 222B 3.31B 22.15B 8.69B 111B 8.77B 8.58B 368B P/E 2026 *
9.69x
P/E 2027 * 8.76x
Enterprise Value 18.33B 2.34B 2.02B 1.89B 1.73B 3.26B 222B 3.31B 22.15B 8.69B 111B 8.77B 8.58B 368B EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.24x
Free-Float
23.76%
Yield 2026 *
4.58%
Yield 2027 * 5.35%
1 day+2.45%
1 week+1.45%
Current month+1.45%
1 month+1.65%
3 months-14.88%
6 months-33.65%
Current year-33.31%
1 week 5.01
Extreme 5.01
5.24
1 month 5.01
Extreme 5.01
5.4
Current year 4.53
Extreme 4.53
8.18
1 year 4.53
Extreme 4.53
9.88
3 years 3.17
Extreme 3.17
10.2
5 years 3.17
Extreme 3.17
10.2
10 years 1.36
Extreme 1.36
10.2
Manager TitleAgeSince
Chief Executive Officer 36 01/06/2021
Corporate Secretary 57 01/09/2011
Director TitleAgeSince
Director/Board Member 63 21/03/2005
Director/Board Member 66 12/05/2011
Director/Board Member 62 31/12/2018
Date Insider Type Main position Quantity % Market Cap.
22/08/25 Other

Chief Executive Officer

45,500 0.0013%
17/06/25 Other

Chairman

50,000 0.0014%
20/05/25 Other

Chief Executive Officer

24,500 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
+2.45%+1.45%-36.62%+22.89% 2.34B
-0.52%+3.21%+89.52%+127.32% 1,057B
+0.88%+1.13%+49.56%+49.69% 625B
+0.89%-1.95%+24.23%+64.44% 435B
+0.71%+3.87%+49.07%+37.85% 363B
+0.64%-0.49%+33.94%+40.01% 296B
+0.39%-5.83%+8.92%+7.85% 249B
+1.51%+6.69%+42.58%+57.57% 222B
+3.92%-0.46%-5.56%-52.32% 209B
+1.80%+2.30%+11.56%+66.35% 165B
Average +1.27%+0.92%+26.72%+42.17% 362.31B
Weighted average by Cap. +0.66%+1.22%+48.67%+64.61%

Financials

2026 *2027 *
Net sales 13.34B 1.7B 1.47B 1.37B 1.26B 2.37B 162B 2.41B 16.11B 6.32B 81.11B 6.38B 6.25B 268B 14.78B 1.88B 1.63B 1.52B 1.4B 2.63B 179B 2.67B 17.85B 7.01B 89.87B 7.07B 6.92B 297B
Net income 1.91B 244M 211M 197M 181M 340M 23.2B 345M 2.31B 907M 11.63B 916M 895M 38.45B 2.09B 266M 230M 215M 197M 371M 25.31B 376M 2.52B 989M 12.68B 998M 977M 41.93B
Net Debt - -
Logo Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the manufacture and sale of pharmaceutical preparations and medical devices. The Company is also engaged in the manufacture and sale of biotechnology products, health products, specialised pharmaceutical raw materials and other products. The Company's main products include nuclear medicine anti-tumor diagnosis and treatment and cardiovascular and cerebrovascular interventional diagnosis and treatment technology products.
Employees
12,614
Date Price Change Volume
07/08/26 HK$5.235 +2.45% 5,095,500
06/08/26 HK$5.110 -0.10% 4,088,600
05/08/26 HK$5.115 +0.99% 4,361,795
04/08/26 HK$5.065 -1.36% 3,892,500
03/08/26 HK$5.135 -0.48% 2,945,702
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.235HKD
Average target price
11.90HKD
Spread / Average Target
+127.32%

Annual profits - Rate of surprise